Aflibercept 8mg in Neovascular AMD and DMO: Insights from PULSAR and PHOTON Trials
Please check back later for more content.
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
Ophthalmic care uncommon after tamoxifen initiation
2
FDA requires NAION warning across the GLP-1 receptor agonist class
3
Retinal gene therapy in 2026: 13 milestones from January through October
4
Training refractive surgeons and expanding access to eye surgery
5